Found: 7
Select item for more details and to access through your institution.
Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.
- Published in:
- CardioRenal Medicine, 2019, v. 9, n. 5, p. 316, doi. 10.1159/000500612
- By:
- Publication type:
- Article
Rilparencel (Renal Autologous Cell Therapy-REACT<sup>®</sup>) for Chronic Kidney Disease and Type 1 and Type 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Redosing Triggers.
- Published in:
- American Journal of Nephrology, 2024, v. 55, n. 3, p. 389, doi. 10.1159/000537942
- By:
- Publication type:
- Article
Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease.
- Published in:
- American Journal of Nephrology, 2015, v. 40, n. 6, p. 535, doi. 10.1159/000369939
- By:
- Publication type:
- Article
Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism.
- Published in:
- Nephrology Dialysis Transplantation, 2005, v. 20, n. 6, p. 1232, doi. 10.1093/ndt/gfh829
- By:
- Publication type:
- Article